BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhu Q, Gao BQ, Zhang JF, Shi LP, Zhang GQ. Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports. World J Clin Cases 2023; 11(11): 2549-2558 [PMID: 37123319 DOI: 10.12998/wjcc.v11.i11.2549]
URL: https://www.wjgnet.com/2307-8960/full/v11/i11/2549.htm
Number Citing Articles
1
Benedetta Tirone, Gerardo Cazzato, Francesca Ambrogio, Caterina Foti, Marco Bellino. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic OptionDiseases 2024; 12(5): 94 doi: 10.3390/diseases12050094
2
Alexandru-Florin Florescu, Oana-Claudia Sima, Claudiu Nistor, Mihai-Lucian Ciobica, Mihai Costachescu, Mihaela Stanciu, Denisa Tanasescu, Florina Ligia Popa, Mara Carsote. Endocrine Perspective of Cutaneous Lichen Amyloidosis: RET-C634 Pathogenic Variant in Multiple Endocrine Neoplasia Type 2Clinics and Practice 2024; 14(6): 2284 doi: 10.3390/clinpract14060179
3
M. Amiot, I. Moulonguet. Amylose papuleuse (« lichen amyloïde »)Annales de Dermatologie et de Vénéréologie - FMC 2024; 4(7): 471 doi: 10.1016/j.fander.2023.10.014